Delayed T cell Response Allows Tuberculosis to Gain Foothold in Monkeys

The results could help guide the design of new vaccines for the disease.

Written byAnna Napolitano, PhD
| 5 min read
Illustration showing rod-shaped Mycobacterium tuberculosis bacteria in the lungs of a person with tuberculosis
Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Tuberculosis kills about 1.5 million people worldwide each year. Among infectious diseases, it’s currently second only to COVID-19 as a cause of death. The interaction of the disease’s causative agent, Mycobacterium tuberculosis (Mtb), with its hosts is complex, and there are many unanswered questions about the infection, including why it can linger in the body for months or years. Now, in a study conducted on monkeys and published in Cell Reports on May 17, University of Pittsburgh researchers find that a key subset of infection-fighting immune cells only become fully active three months after the body first encounters Mtb, with a second subset of these cells emerging five months postinfection. The results suggest that a delayed adaptive immune response might be crucial to Mtb’s ability to establish a foothold in a host.

“That [the] TB immune response is unusual compared to other pathogens had been known for years, but people ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • smiling woman with curly hair and glasses

    Anna Napolitano is a freelance science writer based in London with bylines in several outlets. As a PhD student and as a postdoc, she published several peer-reviewed papers in the immunology field. She then earned a post-graduate certificate in science communication from the University of the West of England and now works as a science writer, editor, and communicator. She collaborated with Mosaic Science, Wellcome Trust’s online open-access long-form publication, and regularly writes for The Naked Scientists and Nature Italy. Read more of her work at annanapolitano.com.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies